PUBLIC NOTICE OF ASSIGNEE SALE: Transcend Company, a direct-pay telehealth platform

Silhouette Advisors LLC is acting as sale agent for TCI (ABC), LLC, solely in its capacity as assignee for the benefit of creditors of Transcend Company, Inc.

Transcend Company operates a direct-pay telehealth platform that connects consumers with licensed professionals to help achieve wellness goals across areas including hormone therapy, peptide therapy, weight management, sexual health, and longevity.

Transcend also supplies the operational infrastructure behind those relationships, including intake, lab, and pharmacy fulfillment coordination, and ongoing patient support.

Transcend’s platform supports a broad range of service lines:

• Hormone therapy – Hormone replacement and testosterone therapy for men and women
• Peptide therapy – Programs focused on recovery, performance, and longevity
• Weight management – Metabolic health and weight-loss programs
• Sexual health – Dedicated programs for both men and women
• Performance and longevity – Athletic performance, healing and recovery, and healthy aging
• Specialty programs – Cognitive clarity, thyroid function, fertility, men’s hair growth, and skin care
• Additional offerings – Standalone diagnostic lab panels, nutritional counseling, and a selection of third-party nutritional supplements

Transcend’s brand assets, including trademarks, social media accounts, and domain names, are available for sale. All data, including but not limited to protected health information (PHI) and personally identifiable information (PII), is excluded from the sale.

Bids are due October 9, 2026, at 12:00 p.m. Eastern Time.
Contact Silhouette Advisors ([email protected]) or see here for more information.